PlainRecalls

Rising Pharmaceuticals

Compiled from official public sources by the publisher.

3 recalls on record · Latest: Mar 1, 2023

Subscribe to new Rising Pharmaceuticals recalls (RSS)

Agency notice ledger

Federal filing book Rising Pharmaceuticals LIGHT-BOOK · SINGLE-AGENCY

#4,009 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #4,009 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Drug (3)
  • CAT children
  • CATS 2 categories
  • LATEST Mar 1, 2023
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

Rising Pharmaceuticals accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Rising Pharmaceuticals sits among 14,151 recalling firms

Rising Pharmaceuticals ranks 4,009th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Rising Pharmaceuticals vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 4009th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Rising Pharmaceuticals in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Rising Pharmaceuticals holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Mar 1, 2023

Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01
FDA Drug Moderate Mar 2, 2022

Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
FDA Drug Moderate Oct 13, 2021

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01

Rising Pharmaceuticals is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar children volume

Nearest multi-notice firms that share this firm's dominant product category.

Actavis South Atlantic LLC 3 Amazon.com, Inc. 3 B @ B Trade Inc. 3 Baby Jogger LLC, of Richmond, Va. 3

Frequently Asked Questions

How many federal recall notices name Rising Pharmaceuticals? ▼
PlainRecalls indexes 3 distinct federal recall events naming Rising Pharmaceuticals, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Rising Pharmaceuticals sit among other recalling firms? ▼
Rising Pharmaceuticals ranks #4,009 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Rising Pharmaceuticals's notices? ▼
FDA Drug accounts for 3 of this firm's 3 indexed notices.
What product category dominates Rising Pharmaceuticals's filing book? ▼
Filings for Rising Pharmaceuticals span 2 product categories, led by children. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Rising Pharmaceuticals: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Rising Pharmaceuticals; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026